Observational studyJournal of cardiac failure2026

Sotagliflozin, suPAR, and Cardiovascular Outcomes in Patients With Diabetes and Heart Failure: A SOLOIST-WHF Ancillary Study.

Anis Ismail et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.